Mainz Biomed N.V. (MYNZ) Operating Margin (2019 - 2025)
Mainz Biomed N.V. (MYNZ) operating margin from Dec 31, 2019 to Dec 31, 2025. The current Mainz Biomed N.V. (MYNZ) operating margin is -2988.89%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Annual Operating Margin change of Mainz Biomed N.V. (MYNZ)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | -2988.89% | +41.72% |
| 2024 | -2108.99% | +0.37% |
| 2024 | -2101.12% | -29.02% |
| 2023 | -2960.00% | -40.67% |
| 2022 | -4988.68% | +197.68% |
| 2021 | -1675.86% | +1125.63% |
| 2020 | -136.73% | -58.39% |
| 2019 | -328.57% | N/A |
Comparison Mainz Biomed N.V. (MYNZ) operating margin with competitors
Mainz Biomed N.V. (MYNZ) operating margin is -2988.89%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| IDXX | Idexx Laboratories Inc | 31.78% | -101.06% |
| SHC | Sotera Health Company | 28.16% | -100.94% |
| MTD | Mettler-Toledo International Inc | 26.00% | -100.87% |
| DHR | Danaher Corp | 22.58% | -100.76% |
| QGEN | Qiagen NV | 22.29% | -100.75% |
| A | Agilent Technologies Inc | 21.74% | -100.73% |
| MEDP | Medpace Holdings Inc | 20.03% | -100.67% |
| ILMN | Illumina Inc | 19.16% | -100.64% |
| TMO | Thermo Fisher Scientific Inc | 16.93% | -100.57% |
| BLLN | Billiontoone Inc - Class A | 16.45% | -100.55% |
| VCYT | Veracyte Inc | 16.28% | -100.54% |
| DGX | Quest Diagnostics Inc | 13.78% | -100.46% |
| IQV | IQVIA Holdings Inc | 12.38% | -100.41% |
| CRL | Charles River Laboratories International Inc | 12.04% | -100.40% |
| LH | Laboratory Corp Of America Holdings | 10.76% | -100.36% |
| RVTY | Revvity Inc | 10.67% | -100.36% |
| ICLR | Icon Plc | 5.37% | -100.18% |
| CDNA | Caredx Inc | 1.02% | -100.03% |